DJIA 17,798.49 -14.90 -0.08%
NASDAQ 5,127.53 11.38 0.22%
S&P 500 2,090.11 1.24 0.06%
market minute promo

company name or ticker

Commit To Purchase Acceleron Pharma At $35, Earn 18.7% Annualized Using Options

Acceleron Pharma's (XLRN) CEO John Knopf on Q4 2014 Results - Earnings Call Transcript

Health Care Sector Update for 03/02/2015: PCRX, ISIS, XLRN

Why JMP Securities Is Watching (And Loving) These 3 Biotech Stocks

Celgene: A Follow-Up To My Bullish Article Of Last Spring

Celgene Corp.'s Expanding Margins

But it wasn't all the healthy kind of expansion.

5 Cant-Miss Reasons Why Celgene Corporation Could Soar

Celgene Corporation has issued long-term guidance that suggests significant sales and profit growth through 2020.

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Insider Trading Alert - XLRN, MOH And PF Traded By Insiders

Insider Trading Alert - EXA, CVV And XLRN Traded By Insiders

See More Articles...